Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Pharmaceuticals
Germany’s Wacker Chemie says it will double its fermentation capacity with the acquisition of SynCo Bio Partners’ microbial products and vaccine facility in Amsterdam. The contract manufacturing site features fermentation lines with capacities of 270 L and 1,500 L as well as fill-and-finish capabilities for finished drugs. Wacker says it will maintain SynCo’s workforce of about 110 employees.
This article has been sent to the following recipient: